Drugmaker GSK says EU to review womb cancer treatment

British pharmaceutical giant GSK said on Tuesday that the EU’s drug watchdog will study a new treatment for a common type of womb cancer for potential approval in the European market.

Leave A Comment

Your email address will not be published. Required fields are marked *